DISCO-CT2: Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography: Long-Term Follow-Up

Sponsor
National Institute of Cardiology, Warsaw, Poland (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06031974
Collaborator
(none)
92
1
14.6
6.3

Study Details

Study Description

Brief Summary

A long-term evaluation of the impact of intensive diet and lifestyle intervention on coronary plaque dynamics in patients with coronary atherosclerosis diagnosed in computed tomography angiography (CCTA).

92 patients who completed the Dietary Intervention to Stop COronart Atherosclerosis in Computed Tomography study (DISCO-CT, NCT02571803) will be followed-up.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DISCO Intervention

Detailed Description

All patients who completed the Dietary Intervention to Stop COronart Atherosclerosis in Computed Tomography received dietary and lifestyle recommendations and were referred to outpatient specialist care at their place of residence.

As part of this study, patients will be invited for a follow-up visit consisting of a cardiological and dietician consultation and additional tests, including CCTA, to assess the long-term impact of the intervention on the progression of atherosclerotic plaques, including high-risk plaque component.

Additionally, the occurrence of cardiovascular events, change in laboratory parameters and change in body weight composition will be analyzed.

Study Design

Study Type:
Observational
Anticipated Enrollment :
92 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography: Long-Term Follow-Up
Actual Study Start Date :
Jan 13, 2023
Anticipated Primary Completion Date :
Jan 13, 2024
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
DISCO Intervention

Patients included to the DISCO-CT study and randomized to the experimental arm, ie. subjected to optimal medical treatment in accordance with European Society of Cardiology recommendations + DASH diet (Dietary Approaches to StopHypertension) and strict monitoring of eating and lifestyle behaviors n=46

Behavioral: DISCO Intervention
optimal medical management in accordance with European Society of Cardiology recommendations + dietary intervention based on Dietary Approaches to Stop Hypertension (DASH diet) + strict monitoring of eating and lifestyle behaviors

Control

Patients included to the DISCO-CT study and randomized to the control arm, ie. subjected to optimal medical treatment in accordance with European Society of Cardiology recommendations alone n=46

Outcome Measures

Primary Outcome Measures

  1. Total Atheroma Volume (Change) [60 months]

    Quantitative assessment of the coronary plaque dynamics will be analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study (expressed in mm3)

  2. Percent Atheroma Volume (Change) [60 months]

    Quantitative assessment of the coronary plaque dynamics will be analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study (expressed in percent) PAV = [(EEM-LA)/EEM]*100% EEM - extrernal elastic membrane area LA - lumen area

Secondary Outcome Measures

  1. Calcified Plaque Volume (Change) [60 months]

    Analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study; calcified plaque volume (expressed in mm3) will be indentified according to plaque density in Hounsfield units, on a per-patient basis

  2. Fibrous Plaque Volume (Change) [60 months]

    Analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study; fibrous plaque volume (expressed in mm3) will be indentified according to plaque density in Hounsfield units, on a per-patient basis

  3. Fibrofatty Plaque Volume (Change) [60 months]

    Analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study; fibrofatty plaque volume (expressed in mm3) will be indentified according to plaque density in Hounsfield units, on a per-patient basis

  4. Necrotic Core (Low Density) Plaque Volume (Change) [60 months]

    Analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study; necrotic (low density) palque volume (expressed in mm3) will be indentified according to plaque density in Hounsfield units, on a per-patient basis

  5. Non-Calcified Plaque Volume (Change) [60 months]

    Analyzed in the coronary computed tomography angiography and compared with parameters measured at the completion of the DISCO-CT study; A combined component of fibrofatty + necrotic (low density) plaque (expressed in mm3), measured on a per-patient basis

  6. Rate of major cardiovascular events [60 months]

    myocardial infarction cardiovascular death coronary revascularization

Other Outcome Measures

  1. Change in body mass [60 months]

    in kilograms

  2. Change in total body fat [60 months]

    expressed in kilograms

  3. Change in skeletal muscle mass [60 months]

    expressed in kilograms

  4. Change in fat to muscle ratio [60 months]

    expressed as the relation of fat mass to muscle mass

  5. Change in epicardial fat volume [60 months]

    semiautomated measurements based on the density in Hounsfield units performed in computed tomography angiography and expressed in cm3

  6. Change in Visceral Fat Area [60 months]

    Measured as part of body composition analysis, expressed in cm2

  7. Change in total cholesterol [60 months]

    mg/dL

  8. Change in low density lipoprotein [60 months]

    mg/dL

  9. Change in the DASH Index [60 months]

    adherence to the DASH plan in 8 main groups of foodstuffs (cerealproducts, vegetables, fruits, dairy products, meat,nuts/seeds, fats/oils, and sweets), with a maximumscore of 10 per group (total 0 to 80)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • completion the DISCO-CT study (NCT02571803)

  • willingness to participate in the long-term follow-up at site

Exlusion criteria:
  • contraindications to perform coronary computed tomography angiography (history of severe reaction to iodine contrast media, uncontrolled thyreotoxicosis and/or severe renal impairment with GFR < 30 ml/min)

  • no consent to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institute of Cardiology Warszawa Poland 04-628

Sponsors and Collaborators

  • National Institute of Cardiology, Warsaw, Poland

Investigators

  • Principal Investigator: Jan Henzel, National Institute of Cardiology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
National Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT06031974
Other Study ID Numbers:
  • 2.25/III/23
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 11, 2023